Revenue: The sum of all revenue fields included for a company's operating activities.
Oncobiologics, Inc. (OTLK) had Revenue of $1.51M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$1.51M |
$-20.15M |
|
$0.44M |
|
$1.07M |
|
$17.25M |
|
$-15.75M |
|
$-4.40M |
|
$-20.15M |
|
$-20.15M |
|
$-20.15M |
|
$-20.15M |
|
$-20.15M |
|
$-20.15M |
|
$-15.75M |
|
$-15.72M |
|
36.96M |
|
36.96M |
|
$-0.55 |
|
$-0.55 |
|
| Balance Sheet Financials | |
$21.10M |
|
-- |
|
$1.30M |
|
$22.39M |
|
$31.49M |
|
$20.44M |
|
$28.09M |
|
$59.58M |
|
$-37.19M |
|
$-37.19M |
|
$-37.19M |
|
43.48M |
|
| Cash Flow Statement Financials | |
$-39.45M |
|
-- |
|
$33.43M |
|
$14.93M |
|
$8.90M |
|
$-6.03M |
|
$7.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.67 |
|
-- |
|
-- |
|
-1.22 |
|
-0.93 |
|
70.78% |
|
-1046.20% |
|
-1046.20% |
|
-- |
|
-1338.75% |
|
-1338.75% |
|
$-39.45M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.11 |
|
0.86 |
|
104.71 |
|
54.19% |
|
54.19% |
|
-90.00% |
|
120.29% |
|
$-0.86 |
|
$-1.07 |
|
$-1.07 |
|